# FDA Inspection 1304716 - Bieffe Medital, S.A. - April 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/bieffe-medital-sa/d7b465da-a3d6-4d95-bb8a-c3e4097e462b
Source feed: FDA_Inspections

> FDA Inspection 1304716 for Bieffe Medital, S.A. on April 11, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304716
- Company Name: Bieffe Medital, S.A.
- Inspection Date: 2025-04-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1304716 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/bieffe-medital-sa/aca9b7ec-28b8-44f1-9923-7628090d94ea)
- [FDA Inspection 1146372 - 2021-04-22](https://www.keypedia.com/records/fda_inspections/bieffe-medital-sa/ce1a471f-eedd-4fcd-963f-ee175159081e)
- [FDA Inspection 988856 - 2016-07-20](https://www.keypedia.com/records/fda_inspections/bieffe-medital-sa/298b81c5-32f5-4971-8fc9-f6141a065995)
- [FDA Inspection 869230 - 2014-02-23](https://www.keypedia.com/records/fda_inspections/bieffe-medital-sa/d1259e02-0310-4d7d-a771-feea1663f7e4)

Company: https://www.keypedia.com/companies/bieffe-medital-sa/28a9d62d-50cd-4f2b-b89b-411f3d71b722